Tonix Pharmaceuticals Holding Corp. (TNXP) — Stock Score Summary

Tonix Pharmaceuticals Holding Corp. (TNXP) has a MoatMap StockRank of 9/100 based on Quality (32/100), Value (42/100), and Momentum (17/100) factor scores. The current signal is STRONG SELL. Tonix Pharmaceuticals is a highly speculative clinical-stage biotech company with a history of heavy dilution and no commercialized products. It fails the Terry Smith quality test and does not possess the validated manufacturing moat of a high-quality CDMO.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on developing therapeutics and biologics to treat central nervous system disorders, immunology, and infectious diseases. The company's primary asset is Tonmya, a late-stage candidate for the management of fibromyalgia. Tonix operates as a high-risk, development-stage biotech player with a diversified pipeline, relying on clinical trial milestones and capital markets to fund its path to commercialization.

Key Financial Metrics

Price$11.46
Market Cap$201M
P/E (Forward)-1.52
Price/Book0.62
Return on Equity-72.3%
Return on Invested Capital-50.3%
Debt/Equity0.57
Gross Margin58.6%
Operating Margin-603.9%
Revenue Growth183.2%
Free Cash Flow$-77M

Tonix Pharmaceuticals Holding Corp. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Tonix Pharmaceuticals Holding Corp.’s (TNXP) StockRank?
MoatMap’s StockRank for Tonix Pharmaceuticals Holding Corp. (TNXP) is 9/100, with a Strong Sell signal. It is a composite of Quality (32), Value (42), and Momentum (17) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tonix Pharmaceuticals Holding Corp. have an economic moat?
Tonix Pharmaceuticals Holding Corp. (TNXP) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tonix Pharmaceuticals Holding Corp. a buy, hold, or sell?
MoatMap’s current signal for Tonix Pharmaceuticals Holding Corp. (TNXP) is Strong Sell, based on a StockRank of 9/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tonix Pharmaceuticals Holding Corp. in?
Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTNXP deep dive reportAI ChampionsHow we score stocksSense-check another stock